Publicaciones en colaboración con investigadores/as de German Cancer Research Center (50)

2023

  1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248

  2. Changes in PRC1 activity during interphase modulate lineage transition in pluripotent cells

    Nature communications, Vol. 14, Núm. 1, pp. 180

  3. GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  4. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  5. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339

  6. Pistachio genomes provide insights into nut tree domestication and ZW sex chromosome evolution

    Plant Communications, Vol. 4, Núm. 3

  7. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2022

  1. A polygenic risk score for multiple myeloma risk prediction

    European Journal of Human Genetics, Vol. 30, Núm. 4, pp. 474-479

  2. Autophagy in Hematological Malignancies

    Cancers, Vol. 14, Núm. 20

  3. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 31, Núm. 9, pp. 1863-1866

  4. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal

2021

  1. Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894

  2. Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

    International Journal of Cancer, Vol. 148, Núm. 7, pp. 1616-1624

  3. Effects of Vimentin Intermediate Filaments on the Structure and Dynamics of in Vitro Multicomponent Interpenetrating Cytoskeletal Networks

    Physical Review Letters, Vol. 127, Núm. 10

  4. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

    International Journal of Cancer, Vol. 149, Núm. 2, pp. 327-336

  5. Genetically determined telomere length and multiple myeloma risk and outcome

    Blood Cancer Journal, Vol. 11, Núm. 4

  6. Polymorphisms within autophagy‐related genes influence the risk of developing colorectal cancer: A meta‐analysis of four large cohorts

    Cancers, Vol. 13, Núm. 6, pp. 1-15

  7. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

2020

  1. Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms

    Blood Cancer Journal, Vol. 10, Núm. 8

  2. Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium

    Blood Cancer Journal, Vol. 10, Núm. 7